Accelerated TMS Shows Promise for Treatment-Resistant Depression

Millions struggle with treatment-resistant depression, a significant mental health challenge. Now, a latest approach to transcranial magnetic stimulation (TMS) is offering hope: an accelerated protocol that delivers the same therapeutic benefit in just five days, potentially expanding access to care and reducing logistical burdens for patients.

Understanding Transcranial Magnetic Stimulation (TMS)

Transcranial magnetic stimulation (TMS) is a non-invasive procedure that uses magnetic pulses to stimulate nerve cells in the brain. Specifically, TMS targets brain regions involved in mood regulation. It’s performed in an outpatient setting and does not require anesthesia. Mayo Clinic explains that TMS is used to improve symptoms of major depression.

Research indicates that TMS can significantly reduce depressive symptoms in 60 to 70% of patients, with remission rates between 25 and 35%, particularly in those who haven’t responded to medication. A study published in the Journal of Affective Disorders highlights the effectiveness of TMS in these cases.

The 5×5 Accelerated Protocol

Traditionally, TMS treatment involves daily sessions over six to eight weeks. The new “5×5” protocol compresses this timeline, delivering five sessions per day for five consecutive days, totaling 25 applications. The goal is to achieve the same therapeutic effect in a much shorter period.

Study Findings: Comparing Accelerated and Conventional TMS

A recent study analyzed 175 patients with treatment-resistant depression, comparing the 5×5 protocol to the standard approach. 135 patients received the standard protocol, while 40 underwent accelerated treatment. Both groups experienced clinically relevant reductions in depressive symptoms, with no statistically significant difference in overall results during the initial follow-up period. The research, published in the Journal of Affective Disorders in 2026, has a DOI of (10.1016/j.jad.2026.121345).

Delayed Effects Observed with Accelerated TMS

Interestingly, some patients in the 5×5 group didn’t show immediate improvement after the five-day treatment period. But, follow-up evaluations conducted two to four weeks later revealed an average 36% reduction in depression symptoms. This suggests that the effects of accelerated brain stimulation can consolidate over time, emphasizing the importance of continued clinical monitoring.

What This Means for the Future of Depression Treatment

While the accelerated protocol shows considerable promise, further validation is needed through randomized clinical trials and long-term analyses. However, reducing treatment from weeks to days could significantly improve patient adherence, increase access to care, and provide a more feasible option for individuals with time constraints or mobility limitations. The Department of Veterans Affairs recognizes TMS as a safe, non-invasive, and effective treatment for depression.

Key Takeaways

• TMS is a non-invasive treatment for depression, particularly effective for those who haven’t responded to antidepressants.
• The 5×5 protocol delivers the same therapeutic benefit as traditional TMS in a significantly shorter timeframe.
• Delayed effects may be observed with the accelerated protocol, highlighting the need for ongoing monitoring.
• Further research is needed to confirm the long-term efficacy and benefits of the 5×5 approach.